# Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial

Study · id `cardio:ct-nct01959451` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01959451](<https://clinicaltrials.gov/study/NCT01959451>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01959451

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2600 participants.

## Technical summary

Registry record NCT01959451. Randomized; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2016-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2600 participants (enrolled count; ClinicalTrials.gov record NCT01959451, source copy `cardio:ctgov-nct01959451-2019-03-01`, retrieved 2026-10-31)
- Start date: 2013-09 (registry gives no type) (ClinicalTrials.gov record NCT01959451, source copy `cardio:ctgov-nct01959451-2019-03-01`, retrieved 2026-10-31)
- Primary completion: 2016-05 (actual) (ClinicalTrials.gov record NCT01959451, source copy `cardio:ctgov-nct01959451-2019-03-01`, retrieved 2026-10-31)
- Completion: 2017-06 (actual) (ClinicalTrials.gov record NCT01959451, source copy `cardio:ctgov-nct01959451-2019-03-01`, retrieved 2026-10-31)
- Countries: Austria; Germany; Hungary; Poland (ClinicalTrials.gov record NCT01959451, source copy `cardio:ctgov-nct01959451-2019-03-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01959451-2019-03-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
- Acronym: TROPICAL-ACS
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Prasugrel
- Intervention (Drug): Clopidogrel
- Lead sponsor: LMU Klinikum
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: LMU Klinikum (`cardio:org-lmu-klinikum`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial (`cardio:pubmed-28855078`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6766ab2b9e8a844d4c78d63094bd8162a306634c9b0feb5216c5051b75b3a547
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
